Pharma’s Productivity Problem: Finding More Blockbuster Drugs
Xconomy
AUGUST 16, 2016
What Booth didn’t say explicitly is that providing only a limited supply of drug candidates in the face of increasing demand is a key element in the venture investment model. A 2011 white paper by Kevin Lalande of Santé Ventures explains why the … Next Page » Reprints | Share: UNDERWRITERS AND PARTNERS.
40 
Let's personalize your content